Minorga 20 mg/ml skin solution 60 ml

Minorga 20 mg/ml skin solution 60 ml
Minorga 20 mg/ml skin solution 60 ml
For the treatment of alopecia in adults aged 18 to 65 years.

The only minoxidil suitable for long-term use in patients with androgenetic alopecia that has a proven effect¹

3 reasons why MINORGA
MINORGA 20 mg/ml skin solution
Minorga is used to treat hair loss (androgenetic alopecia) in both men and women. In the form of a solution, it is applied directly to the scalp. The product is particularly suitable for men suffering from hair loss or weakening of the hair on the top of the head and also for women who suffer from general hair loss.

Dosage
Apply 1 dose (1 ml = 7 sprays) of the product directly to the affected area of the scalp twice a day, morning and evening. Apply only to dry hair and scalp. The total daily dose should not exceed 2 ml. Wash your hands after each application. The growth of new hair is gradual and variable. It is necessary to apply the product twice a day for at least 4 months. If you do not observe any results within 4 months, consult your doctor for further use.


Ingredients
The active substance is minoxidilum 2.8 mg in one shot. For the application of approximately 1 ml of a solution containing minoxidilum 20 mg, 7 squirts of the spray are needed.

Storage
Keep this product out of sight and reach of children. A flammable product. Protect from heat. Store in a tightly closed container. Do not use this product after the expiry date stated on the bottle after "EXP".
Notice
Minorga contains propylene glycol, which may cause skin irritation. Apply only to normal healthy scalp. Patients with cardiovascular disease or cardiac arrhythmia must consult a physician before using the product. Do not swallow, do not inhale
Manufacturer:LABORATOIRES BAILLEUL, s. r. o.
Read the package insert carefully. Minorga is a medicinal product for cutaneous administration. Contains minoxidil. The medicine is not covered by public health insurance.
¹current Summary of Product Characteristics for Minorga 20 mg/ml.
²The study by Olsen EA et al. J Am Acad Dermatol 2002. 3) Current Patient Package Insert for Minorga 20 mg/ml and 50 mg/ml. * vs alternative minoxidil 2%
Specifications
Active ingredient
Category
Form
Usage
Packaging
Identifiers
Product characteristics
| Code: | SPToth0620 |
| Warranty: | 24 months |
| Manufacturer information |
Laboratoires Bailleul, s.r.o., Pobřežní 620/3, 18600 Praha 8, +420702127331 |